TETANUS IN THE HORSE - A REVIEW OF 20 CASES (1970 TO 1990)

被引:38
作者
GREEN, SL
LITTLE, CB
BAIRD, JD
TREMBLAY, RRM
SMITHMAXIE, LL
机构
[1] Department of Molecular Biosciences, School of Veterinary Medicine, University of California, Davis
[2] Raymond Purves Research Laboratories, University of Sydney, The Royal North Shore Hospital of Sydney, St Leonards, New South Wales
[3] Department of Clinical Studies, Ontario Veterinary College, University ofGuelph, Guelph, Ontario
[4] Animal Industry Branch, Ontario Ministry of Agriculture and Food, Kemptville, Ontario
关键词
D O I
10.1111/j.1939-1676.1994.tb03210.x
中图分类号
S85 [动物医学(兽医学)];
学科分类号
0906 ;
摘要
The case records of 20 horses with tetanus referred to the Ontario Veterinary College‐Veterinary Teaching Hospital between 1970 and 1990 were reviewed. The fatality rate was 75%. There was a strong association with previous vaccination and survival (P= .03). Most of the animals had been injured an average of 9 days (range 2 to 21 days) prior to development of clinical signs. Hyperesthesia and prolapse of the third eyelid were the most common clinical signs. Treatment regimens varied during hospitalization; however, all horses received parenteral penicillin, tranquilizers, tetanus toxoid, and antitoxin. Five of the nonsurviving animals were given intrathecal tetanus antitoxin. One animal had seizures as a complication of intrathecal treatment. The prognosis was best for horses that (1) had been vaccinated prior to the injury, (2) responded to the phenothiazine tranquilizers, and (3) did not rapidly (over 24 to 48 hours) become recumbent. Considering the species susceptibility, potential for contaminated wounds, and the increased survival of vaccinated horses, yearly revaccination is recommended. © 1994 American College of Veterinary Internal Medicine
引用
收藏
页码:128 / 132
页数:5
相关论文
共 38 条
[31]  
Tennant B., pp. 465-471, (1978)
[32]  
Saunders RKM, Joseph R., Martyn B., Et al., Intrathecal antitetanus serum (horse) in the treatment of tetanus, Lancet, 1, pp. 974-977, (1977)
[33]  
Muylle E., Oyaert W., Ooms L., Et al., Treatment of tetanus in the horse by injections of tetanus antitoxin into the subarachnoid space, J Am Vet Med Assoc, 167, pp. 47-48, (1975)
[34]  
Simonsen O., Kjeldsen K., Heron I., Immunity against tetanus and effect of revaccination 25–30 years after primary vaccination, Lancet, 2, pp. 1240-1242, (1984)
[35]  
Berger SA, Cherubin CE, Nelson S., Et al., Tetanus despite preexisting antitetanus antibody, J Am Med Assoc, 240, pp. 769-770, (1978)
[36]  
Wintzer HJ, Korber HD, Holland U., Zur Tetanusprophylaxe beim Pferd, Berl Munch Tierarztl Wochenschr, 88, pp. 181-183, (1975)
[37]  
Lohrer J., Radvila P., Aktive Tetanusprophylaxe beim Pferd und Immunitätsdauer, Schweiz Arch Tierheilkd, 112, pp. 307-314, (1970)
[38]  
Jansen BC, Knoetze PC., The immune response of horses to tetanus toxoid, Onderstepoort J Vet Res, 46, pp. 211-216, (1979)